Department of Anaesthesiology, Ibra Hospital, Ministry of Health-Oman, Ibra-414, Sultanate of Oma.
Department of Cardiac Anesthesia, National Heart Center, Royal Hospital, Muscat, Oman.
Ann Card Anaesth. 2023 Jul-Sep;26(3):247-259. doi: 10.4103/aca.aca_148_22.
Ultrasound-guided erector spinae plane block (ESPB) has been used in many studies for providing opioid-sparing analgesia after various cardiac surgeries. We performed a systematic review and meta-analysis of randomized controlled trials to assess the efficacy of ESPB in cardiac surgeries. We searched PubMed, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), and Google Scholar to identify the studies in which ESPB was compared with the control group/sham block in patients undergoing cardiac surgeries. The primary outcomes were postoperative opioid consumption and postoperative pain scores. The secondary outcomes were intraoperative opioid consumption, ventilation time, time to the first mobilization, length of ICU and hospital stay, and adverse events. Out of 607 studies identified, 16 studies (n = 1110 patients) fulfilled inclusion criteria and were used for qualitative and quantitative analysis. Although, 24-hr opioid consumption were comparable in both groups group (MD, -18.74; 95% CI, -46.85 to 9.36, P = 0.16), the 48-hr opioid consumption was significantly less in ESPB group than control ((MD, -11.01; 95% CI, -19.98 to --2.04, P = 0.02). The pain scores at various time intervals and intraoperative opioid consumption were significantly less in ESPB group. Moreover, duration of ventilation, time to the first mobilization, and length of ICU and hospital were also less in ESPB group (P < 0.00001, P < 0.00001, P < 0.00001, and P < 0.0001, respectively). This systematic review and meta-analysis demonstrated that ESPB provides opioid-sparing perioperative analgesia, facilitates early extubation and mobilization, leads to early discharge from ICU and hospital, and has lesser pruritus when compared to control in patients undergoing cardiac surgeries.
超声引导竖脊肌平面阻滞(ESPB)已在许多研究中用于提供各种心脏手术后的阿片类药物节约性镇痛。我们进行了系统评价和荟萃分析,以评估 ESPB 在心脏手术中的疗效。我们在 PubMed、Embase、Cochrane 中央对照试验注册库(CENTRAL)和 Google Scholar 中搜索了将 ESPB 与心脏手术患者的对照组/假阻滞进行比较的研究。主要结果是术后阿片类药物消耗和术后疼痛评分。次要结果是术中阿片类药物消耗、通气时间、首次活动时间、ICU 和住院时间以及不良事件。在 607 项研究中,有 16 项研究(n = 1110 名患者)符合纳入标准,并进行了定性和定量分析。尽管两组 24 小时阿片类药物消耗无差异(MD,-18.74;95%CI,-46.85 至 9.36,P = 0.16),但 ESPB 组的 48 小时阿片类药物消耗明显低于对照组(MD,-11.01;95%CI,-19.98 至-2.04,P = 0.02)。ESPB 组在各个时间间隔的疼痛评分和术中阿片类药物消耗均明显减少。此外,ESPB 组的通气时间、首次活动时间以及 ICU 和住院时间也较短(P < 0.00001、P < 0.00001、P < 0.00001 和 P < 0.0001,分别)。这项系统评价和荟萃分析表明,与对照组相比,ESPB 可提供围手术期阿片类药物节约性镇痛,促进早期拔管和活动,促进 ICU 和医院的早期出院,并减少瘙痒。